Cardiovascular disease risk and Lung cancer screening for Early Assessment of Risk (project CLEAR) in Missouri: A protocol for a mixed methods study.

ABSTRACT:

Background

Lung cancer and atherosclerotic cardiovascular disease (ASCVD) are leading causes of mortality in the United States, sharing common risk factors like smoking and age. Preventive care for these conditions is often siloed, leading to missed opportunities to prevent ASCVD-related mortality in lung cancer screening (LCS) patients. In various trial settings, patients undergoing LCS were more likely to die from ASCVD than from cancer; however, less than half of eligible patients got statin prescription. This study aims to understand the degree to which ASCVD risk assessment and prevention is done in routine "real-world" clinical settings providing LCS in Missouri. Our objectives are to determine the prevalence of statin eligibility, statin prescription and explore factors, dis

SUBMITTER: Odeny B 

PROVIDER: S-EPMC12258762 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature